Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha
Open Access
- 18 November 2016
- journal article
- research article
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 40 (1-2) , 77-90
Abstract
Background/Aims: Signal transducer and activator of transcription (STAT) pathway plays an important role in antiviral efficacy of interferon alpha (IFN-α). IFN-α is the main therapeutic against hepatitis C virus (HCV) infection. We explored effects of IFN-α on HCV replication and antiviral gene expression by targeting STAT. Methods: In response to IFN-α, STAT status, HCV replication, and antiviral gene expression were analyzed in human hepatoma Huh7.5.1 cells before and after cell culture-derived HCV infection. Results: IFN-α treatment induced expression and phosphorylation of STAT1 and STAT2 in Huh7.5.1 cells. Pretreatment of Huh7.5.1 cells with a mAb to IFN alpha receptor (IFNAR) 2 decreased IFN-α-dependent phosphorylation of STAT1 and STAT2, whereas pretreatment with an IFNAR1 mAb increased such phosphorylation, suggesting that IFNAR mediates IFN-α-triggered STAT signaling. During HCV infection, STAT1 and STAT2 phosphorylation could be rescued by IFN-α and IFN-α-induced phosphorylation of STAT1 and STAT2 was impaired. Inhibition of STAT pathway by Jak inhibitor I significantly enhanced HCV RNA replication and viral protein expression. Antiviral genes coding for IFN regulatory factor 9 and IFN-stimulated gene 15 were up-regulated by IFN-α during HCV infection but such up-regulation was abrogated by Jak inhibitor I. Conclusion: These results establish that activation of STAT pathway is essential for anti-HCV efficacy of IFN-α. Impairment of IFN-α-triggered STAT signaling by HCV may account for evading IFN-α response.Keywords
This publication has 26 references indexed in Scilit:
- Hepatitis C virus targets the interferon‐α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytesFEBS Letters, 2013
- Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cellsCytokine, 2013
- Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signalingVirology, 2013
- Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirinAntiviral Research, 2012
- Suppression of interferon-α signaling by hepatitis E virusHepatology, 2011
- Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture modelsHepatology, 2010
- Altered interferon-α-signaling in natural killer cells from patients with chronic hepatitis C virus infectionJournal of Hepatology, 2010
- Interferon-α-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathwayJournal of Gastroenterology, 2009
- Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin†Hepatology, 2009
- Hepatitis delta virus inhibits alpha interferon signaling #Hepatology, 2009